De mest hyppigt rapporterede bivirkningsreaktioner var reaktioner på applikationsstedet (Kentera 23, 1%, placebo 7, 6%).
The most commonly reported adverse drug reactions were application site reaction (Kentera 23.1%, placebo 7.6%).